Comments
Loading...
Vertex Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:VRTX | Benzinga
Vertex Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 5
EPS
$4.060
Quarterly Revenue
$2.77B
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$11.10B
Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals | -$12.83 | — | — | — | $2.65B | — | — | — | 07/31/2025 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $4.76 | $4.29 | $4.06 | -5.36% | $2.69B | $2.86B | $2.77B | -3.15% | 05/05/2025 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $4.20 | $4.02 | $3.98 | -1.00% | $2.52B | $2.78B | $2.91B | 4.75% | 02/10/2025 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $4.08 | $4.14 | $4.38 | 5.80% | $2.48B | $2.72B | $2.77B | 1.91% | 11/04/2024 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $3.89 | $4.14 | -$12.83 | -409.90% | $2.49B | $2.66B | $2.65B | -0.53% | 08/01/2024 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $3.05 | $4.02 | $4.76 | 18.41% | $2.38B | $2.57B | $2.69B | 4.67% | 05/06/2024 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $3.76 | $4.10 | $4.20 | 2.44% | $2.30B | $2.51B | $2.52B | 0.31% | 02/05/2024 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $4.01 | $3.98 | $4.08 | 2.51% | $2.33B | $2.50B | $2.48B | -0.64% | 11/06/2023 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $3.60 | $3.85 | $3.89 | 1.04% | $2.20B | $2.41B | $2.49B | 3.44% | 08/01/2023 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $3.52 | $3.00 | $3.05 | 1.67% | $2.10B | $2.34B | $2.38B | 1.50% | 05/01/2023 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $3.37 | $3.51 | $3.76 | 7.12% | $2.07B | $2.30B | $2.30B | 0.13% | 02/07/2023 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $3.56 | $3.67 | $4.01 | 9.26% | $1.98B | $2.23B | $2.33B | 4.66% | 10/27/2022 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $3.11 | $3.52 | $3.60 | 2.27% | $1.79B | $2.13B | $2.20B | 3.10% | 08/04/2022 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $2.98 | $3.49 | $3.52 | 0.86% | $1.72B | $2.08B | $2.10B | 0.82% | 05/05/2022 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $2.51 | $3.29 | $3.37 | 2.43% | $1.63B | $2.00B | $2.07B | 3.65% | 01/26/2022 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $2.64 | $3.08 | $3.56 | 15.58% | $1.54B | $1.86B | $1.98B | 6.67% | 11/02/2021 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $2.61 | $2.28 | $3.11 | 36.40% | $1.52B | $1.72B | $1.79B | 4.24% | 07/29/2021 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $2.56 | $2.69 | $2.98 | 10.78% | $1.51B | $1.66B | $1.72B | 3.86% | 04/29/2021 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $1.70 | $2.59 | $2.51 | -3.09% | $1.26B | $1.58B | $1.63B | 3.04% | 02/01/2021 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $1.23 | $2.32 | $2.64 | 13.79% | $949.83M | $1.47B | $1.54B | 4.63% | 10/29/2020 | Get Alert |
| VRTX | Vertex Pharmaceuticals | $1.26 | $2.07 | $2.61 | 26.09% | $941.28M | $1.39B | $1.52B | 9.64% | 07/30/2020 | Get Alert |
Vertex Pharmaceuticals (VRTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-05 | $4.06 | $4.29 | -5.36 % |
| Q4 | 2025-02-10 | $3.98 | $4.02 | -1.00 % |
| Q3 | 2024-11-04 | $4.38 | $4.14 | 5.80 % |
| Q2 | 2024-08-01 | $-12.83 | $4.14 | -409.9 % |
Vertex Pharmaceuticals (VRTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-05 | $2.77B | $2.86B | -3.15 % |
| Q4 | 2025-02-10 | $2.91B | $2.78B | 4.75 % |
| Q3 | 2024-11-04 | $2.77B | $2.72B | 1.91 % |
| Q2 | 2024-08-01 | $2.65B | $2.66B | -0.53 % |
FAQ
When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?
Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on July 31, 2025. The last reported earnings were for reported on May 5, 2025 for Q1.
What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?
The Actual EPS was $4.06, which missed the estimate of $4.29.
What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?
The Actual Revenue was $2.8B, which missed the estimate of $2.9B.
Browse earnings estimates, EPS, and revenue on all stocks.
